Recognizing and Addressing Hyperphagia Early in Prader-Willi Syndrome

Strategies and Insights for Pediatric Endocrinologists and Their Care Team

  • Saturday, April 26, 2025
  • 12:00 pm - 1:30 pm ET
  • CME, CNE
  • Virtual
Overview

Join us for this live symposium on Prader Willi syndrome (PWS) where our expert faculty will explore the huge burden that hyperphagia represents for patients with PWS, their families, and their caregivers. They will delve into the pathophysiology and complications of hyperphagia and look to the future in a discussion around the current and emerging treatment options for hyperphagia in PWS. By incorporating patient case examples and the latest data, the faculty will exchange ideas around best practices to ensure improved quality of life for patients with PWS and those around them. There will be the opportunity for attendees to ask questions of the experts during this symposium.
Speakers
Speaker Image
Shawn McCandless, MD
FACULTY

Chair, Department of Genetics and Metabolism

​​Children's Hospital Colorado

​​Professor and Section Head, Genetics and Metabolism

​​University of Colorado Anschutz Medical Campus

Aurora, Colorado​​​

Speaker Image
Parisa Salehi, MD
FACULTY

Associate Professor

Division of Endocrinology & Diabetes

​Clinical Director, Prader-Willi Syndrome Clinic

​Seattle Children's

​Seattle, Washington​

Speaker Image
Deepan Singh, MD
FACULTY

​Child, Adolescent, and Adult Psychiatrist

​Vice-Chair of Ambulatory Psychiatry Services

​Maimonides Medical Centre

Brooklyn, New York​

Agenda

The PWS patient journey

Revisiting the basics to move care forward

Looking to the future of PWS treatment

Summary and key clinical takeaways

Q&A

Backstage Pass

Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.

*Video encouraged*

Program Information
Accreditation Statement
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Accreditation logos
Accreditation logos
[bold]For Physicians[/bold][break] Medscape, LLC designates this live activity for a maximum of 1.0 [italic]AMA PRA Category 1 Credits[/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.[break] [break] [bold]For Nurses[/bold] [break] Awarded ​1.0​ contact hour(s) of nursing continuing professional development for RNs and APNs.
Learning Objectives
Upon completion of this activity, participants will: [break][break] [LIST][ITEM]Identify the burden of hyperphagia associated with PWS on patients[ITEM] Discuss the pathophysiology of hyperphagia and its associated complications in people with PWS [ITEM]Recognize current guideline-based treatment strategies for hyperphagia and PWS [ITEM] Analyze new and emerging treatments for hyperphagia and PWS[/LIST]
Goal Statement
The goal of this activity is to improve clinicians’ awareness, understanding, appreciation, and management of hyperphagia in people with PWS.
Target Audience
This educational activity is intended for an audience of pediatricians, endocrinologists, psychiatrists, geneticists, nurse practitioners, physician assistants, nurses, and other clinicians who care for patients with PWS in the United States.

This is an independent Industry-Supported Symposia. The content and views expressed may not represent those of PES or associated organizations. PES was NOT involved in the development of the session content.

Supported by an independent educational grant from Soleno Therapeutics Inc.